Reliant Investment Partners’s Astera Labs ALAB Stock Holding History

Reliant Investment Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,530	Closed	-$732K	–	114
2024 Q4	$732K	Buy	+5,530	New	+$519K	0.65%	33

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Reliant Investment Partners's ALAB Position: Q1 2025 in Review

Reliant Investment Partners sold out of Astera Labs (ALAB) in Q1 2025, closing a stake of 5,530 shares — an estimated $732K sold.

Reliant Investment Partners first reported a position in ALAB in Q4 2024 and held it in 1 quarter. The position peaked at $732K in Q4 2024. 389 funds tracked by Wall St. Rank hold ALAB as of Q1 2025.

Reliant Investment Partners reported no remaining Astera Labs position as of Q1 2025 after selling out during the quarter.
Reliant Investment Partners sold 5,530 Astera Labs shares in Q1 2025, an estimated $732K.
Reliant Investment Partners first reported a position in Astera Labs in Q4 2024 and held it in 1 quarter.
Reliant Investment Partners's Astera Labs position peaked at $732K in Q4 2024.
389 funds tracked by Wall St. Rank held Astera Labs as of Q1 2025.

Based on Reliant Investment Partners's 13F filing for Q1 2025, filed 21 May 2025.